Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients stand to benefit.
Category: Third World and Developing Countries
-
‘Miracle’ Cystic Fibrosis Drug Kept Out of Reach in Developing Countries
The New York Times – Business: -
Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nations
The New York Times – Business:Separately, Johnson & Johnson is demanding additional payment for unwanted shots, confidential documents show.
-
A Powerful Climate Leader From a Small Island Nation
The New York Times – Business:Mia Mottley, the prime minister of Barbados, has been drawing attention to the environmental and financial threats faced by small and vulnerable countries like hers.
-
Defaults Loom as Poor Countries Face an Economic Storm
The New York Times – Business:Debt-relief efforts are stalling as developing economies are being hit by higher interest rates, a strong dollar and slowing global growth.
-
Britain Scales Back Foreign Aid, Threatening Progress in Global Health
The New York Times – Business:The nation is often the second-largest donor to groups working in poor countries to prevent and treat infectious diseases, and to provide reproductive health services to women.